'ILICs' Are Not Everything In Polar Retention

Article

A reader response to Incognito's article featured in the May issue of The Column.

In the May issue of The Column, we heard the views of our regular columnist Incognito on the hype surrounding hydrophilic interaction chromatography (HILIC) as the new ‘best thing’ in HPLC. One of our readers responded with some interesting points to add to this discussion and we have pleasure in sharing them with you.

Click here for the full article in The Column

Related Videos
Toby Astill | Image Credit: © Thermo Fisher Scientific
Robert Kennedy
Related Content
Business Insight: A Deep Dive into Bruker’s New Mass Spectrometry Division

Business Insight: A Deep Dive into Bruker’s New Mass Spectrometry Division

April 23rd 2024
Article

LCGC International sat down with Jeff Zonderman, senior vice president of Bruker Applied MS at Analytica, to discuss sustainability, PFAS analysis, and the company’s year-old mass spectrometry division.

Ep. 23: Color My World: The Complexities of Color Measurements

Ep. 23: Color My World: The Complexities of Color Measurements

April 1st 2024
Podcast
Site Logo

NanoPak-C All Carbon Solid Phase Extraction (SPE) of Organochlorine Pesticide from Trace Amounts of Environmental Samples

April 23rd 2024
Article

We present a reliable NanoPak-C All Carbon SPE method for extracting and detecting 15 OCPs from small quantities of soil (100 mg) and river water (200 µL) samples.

Ep. 22: Around the world with The Multidimensional Chromatography Workshop

Ep. 22: Around the world with The Multidimensional Chromatography Workshop

March 7th 2024
Podcast
Powerful Triple Detector for GPC/SEC

Powerful Triple Detector for GPC/SEC

April 22nd 2024
Article
Human liver model on doctor's table, close-up. Treatment of hepatitis, cirrhosis and liver cancer | Image Credit: © Peakstock - stock.adobe.com

Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System

April 22nd 2024
Article

Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.